Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure

Sotagliflozin improved symptoms, physical limitations, and quality of life within 4 months after worsening HF, with consistent benefits across baseline demographic and clinical characteristics. (Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure [SOLOIST-WHF]; NCT03521934).

Authors

Institutions

Publication Details

Journal
Journal of the American College of Cardiology
Published
2024-09-01
DOI
https://doi.org/10.1016/j.jacc.2024.06.036
Citations
8
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
2.86
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure

Philippe Gabríel Steg, Deepak L. Bhatt, Jeffrey Moore Testani, Christopher P. Cannon et al.
8 citations
Journal of the American College of Cardiology
Diabetes Treatment and Management
2.86
article

Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure

Philippe Gabríel Steg, Deepak L. Bhatt, Jeffrey Moore Testani, Christopher P. Cannon, Mikhail Kosiborod, Marco Metra, Julia B. Lewis, Ankeet S. Bhatt, Lars H. Lund, Darren K. McGuire, Michael J. Szarek, Adriaan A. Voors, Lawrence A. Leiter, Matthew C. Riddle, Michael J. Davies, Christopher S. Wilcox, Bertram Pitt
article en
8 citations

Abstract

Sotagliflozin improved symptoms, physical limitations, and quality of life within 4 months after worsening HF, with consistent benefits across baseline demographic and clinical characteristics. (Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure [SOLOIST-WHF]; NCT03521934).

Journal of the American College of CardiologyVol. 84(12)
Brigham and Women's Hospital (US), Parkland Health & Hospital System (US), St. Michael's Hospital (CA), University Medical Center Groningen (NL), Karolinska University Hospital (SE), Saint Luke's Health System (US), Harvard University (US), Inserm (FR), Oregon Health & Science University (US), University of Groningen (NL), SUNY Downstate Health Sciences University (US), Georgetown University (US), Université Paris Cité (FR), University of Michigan (US), Karolinska Institutet (SE), Yale University (US), Lexicon Pharmaceuticals (United States) (US), Southwestern Medical Center (US), Assistance Publique – Hôpitaux de Paris (FR), Mount Sinai Hospital (US), Mount Sinai Hospital (US), Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT), Kaiser Permanente San Francisco Medical Center (US), Saint Luke's Hospital (US), Alliance nationale pour les sciences de la vie et de la santé (FR), University of Brescia (IT), The University of Texas Southwestern Medical Center (US), Vanderbilt University Medical Center (US)
Good health and well-being
Openalex Percentile: Top 8%
Diabetes Treatment and Management
2.86
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.